Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II lithium augmentation after non-response to venlafaxine or imipramine in depression
ISRCTN75768415Phase 2Completed
- Sponsor
- Erasmus MC
- Start
- Jun 2005
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of lithium, venlafaxine and imipramine in major depressive disorder (MDD) (2 arms), sponsored by Erasmus MC. Primary endpoints: Change in Hamilton Rating Scale for Depression score and Change in Clinical Global Impression score. Started Jun 2005; status: completed.
02
Drugs
lithiumvenlafaxineimipramine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on ISRCTN75768415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN75768415.